2 results
Approved WMOCompleted
Does oral simvastatin at standard doses alter BMP pathway signalling in colorectal cancer specimens in humans?
Approved WMOCompleted
- to evaluate the FVIIa activity PK of 2 CSL689 dose levels in subjects with congenital FVII deficiency- to determine the PK characteristics of FVIIa activity of CSL689- to evaluate the safety and tolerability of intravenous administration of CSL689